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Abstract
Background: Pelota (PELO) is an evolutionary conserved protein, which has been reported to be involved in the 
regulation of cell proliferation and stem cell self-renewal. Recent studies revealed the essential role of PELO in the No-
Go mRNA decay, by which mRNA with translational stall are endonucleotically cleaved and degraded. Further, PELO-
deficient mice die early during gastrulation due to defects in cell proliferation and/or differentiation.
Results: We show here that PELO is associated with actin microfilaments of mammalian cells. Overexpression of 
human PELO in Hep2G cells had prominent effect on cell growth, cytoskeleton organization and cell spreading. To find 
proteins interacting with PELO, full-length human PELO cDNA was used as a bait in a yeast two-hybrid screening assay. 
Partial sequences of HAX1, EIF3G and SRPX protein were identified as PELO-interacting partners from the screening. 
The interactions between PELO and HAX1, EIF3G and SRPX were confirmed in vitro by GST pull-down assays and in vivo 
by co-immunoprecipitation. Furthermore, the PELO interaction domain was mapped to residues 268-385 containing 
the c-terminal and acidic tail domain. By bimolecular fluorescence complementation assay (BiFC), we found that 
protein complexes resulting from the interactions between PELO and either HAX1, EIF3G or SRPX were mainly localized 
to cytoskeletal filaments.
Conclusion: We could show that PELO is subcellularly localized at the actin cytoskeleton, interacts with HAX1, EIF3G 
and SRPX proteins and that this interaction occurs at the cytoskeleton. Binding of PELO to cytoskeleton-associated 
proteins may facilitate PELO to detect and degrade aberrant mRNAs, at which the ribosome is stalled during 
translation.
Background
The Pelota gene (Pelo) encodes an evolutionary con-
served protein which has been identified in various spe-
cies [1-3]. The protein contains an RNA binding domain
similar to that found in members of the eukaryotic
release factor 1 (eRF1) family, which are involved in ter-
minal stop of protein synthesis [4].
The biological role of PELO was originally identified in
D. melanogaster. In male mutants, mitosis during germ
cell development is normally progressed, but the cell
cycle of the first meiotic division is arrested in late pro-
phase stage. On the contrary, during oogenesis only
mitotic division is affected. Moreover, the eye of mutant
flies has disordered ommatidial array and the orientation
of bristles suggests the impairment of planar cell polarity
during eye development [5]. The role of PELO in meiotic
and mitotic division was also confirmed in S. cerevisiae,
where the deletion of the Pelo orthologue gene DOM34
causes growth retardation and defective sporulation. The
decrease of polyribosomal and increase of free ribosomal
fraction in dom34? mutants suggest a participation of
PELO in the machinery of protein synthesis or in the reg-
ulation of mRNA translation [4].
Translational control of eukaryotic gene expression
plays an essential role in the development and differentia-
tion of cells and provides an important checkpoint for cell
growth and differentiation. Deletion of the Pelo gene in
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mice revealed that PELO-deficient embryos failed to
develop after implantation. Culture of blastocyts in vitro
demonstrated the failure of mitotically active inner cell
mass (ICM) of Pelo-/- blastocysts to expand in growth.
These results suggest that PELO is essential for regula-
tion of the cell cycle during gastrulation [6]. Another
interpretation for the failure of the ICM to proliferate
might be due to the fact that stem cells of Pelo-/- embryos
fail to self-renewal. The role of PELO in control of germ
stem cell (GSC) self-renewal has already been shown in
D. melanogaster [7]
To further elucidate the possible function of PELO, we
searched for proteins that bind to PELO. We performed a
yeast two-hybrid screen using PELO as a bait. Several
positive clones including HAX1, EIF3G and SRPX were
isolated. Using GST pull-down assay and co-immunopre-
cipitation, we confirmed the specific interactions of
PELO with the putative interacting proteins and found
that the c-terminal and acidic tail domains are responsi-
ble for the interactions with partner proteins. To further
support the specificity of interactions between PELO and
its putative partners and to determine the subcellular
localization of the interacting proteins, we performed
bimolecular fluorescence complementation assay (BiFC),
and observed that protein complexes resulting from the
interactions between PELO and either HAX1, EIF3G or
SRPX are associated with the cytoskeleton.
Results
PELO is subcellularly localized at the actin microfilaments
RNA analysis revealed ubiquitous expression of Pelo
[2,3]. To determine the subcellular localization, anti-
PELO antibodies were generated against a GST-PELO
fusion protein containing the full-length human amino
acid sequence. Affinity-purified GST-PELO antibodies
predominantly detected a 44 kDa protein band (Figure
1A, left panel), which is consistent with the predicted
molecular mass of PELO. Detection of the 44 kDa protein
was greatly reduced or even not found after preabsorp-
tion of the antibody with the antigen, to which it was,
raised (Figure 1A, right panel). PELO expression was then
examined by Western blot analysis and immunohis-
tochemistry. Western blot analysis showed that anti-
PELO recognizes the 44 kDa protein band in a wide vari-
ety of mammalian cells and tissues (Figure 1B). The sub-
cellular localization of PELO was firstly studied by
western blot analysis, we used two different biochemical
fractionation techniques as described in Methods part to
produce cytoskeletal, cytoplasmic, nuclear and mem-
brane extracts. Purity of the fractions was assessed by
examining each fraction for the presence or absence of α-
actinin, a cytoskeletal marker, and phospho H3 histone, a
nuclear marker. As expected, α-actinin and phospho-his-
tone H3 were only found in the cytoskeletal and nuclear
fractions, respectively. PELO was exclusively present in
the cytoskeletal and in the membrane fractions (Figure
1C). The proportion of PELO in the cytoskeletal fraction
was higher than that in the membrane fraction. To con-
firm the association of PELO with the cytoskeleton, cul-
tured primary fibroblast was immunofluorescently
stained with anti-PELO antibody. A fibrillar staining pat-
tern was observed in the cytoplasm. PELO also localized
at some regions of plasma membrane and near the
nuclear membrane presumably to the endoplasmic retic-
ulum (Figure 1D, panel i, iv). To study whether PELO is
associated with the actin cytoskeleton, cells were probed
with FITC-labelled phalloidin that stains polymerized F-
actin (Figure 1D, panel ii, v). Overlay images demonstrate
co-localization of F-actin and PELO (Figure 1D, panel iii,
vi), that implies that PELO is associated with actin micro-
filaments. This result is consistent with that obtained by
Western blot analysis.
Figure 1 Subcellular localization of PELO at the cytoskeleton. A, 
Competition assay to determine the specificity of PELO antibodies. 
Blots with testis and lung protein extracts were incubated with anti-
PELO antibodies in presence (+) or absence (-) of the GST-PELO fusion 
protein. B, Immunoblot with cellular extracts from different tissues was 
probed with anti-PELO antibodies. C, PELO is distributed in cytoskeletal 
and membrane fractions. Immunoblots with cellular extracts from dif-
ferent tissues were probed with anti-PELO antibodies. Blots containing 
samples of cytoskeletal (CS), cytoplasmic (C), nuclear (N) and mem-
brane (M) fractions from HeLa cells were subsequently probed with 
polyclonal anti-PELO, monoclonal anti-α-actinin, anti-phospho H3 his-
tone and anti-α-tubulin. D, Co-localization of the PELO antigen and ac-
tin stress fibers. Fibroblasts were immunolabeled with PELO antibodies 
(i, iv) or FITC-phalloidin (ii, v). PELO immunostaining was localized at 
the cytoskeleton (white arrows), at some regions of plasma membrane 
(yellow arrowhead), and near nuclear membranes (white arrowhead). 
The merged images (iii, vi) show that PELO largely co-localized with ac-
tin-stress fibers. Scale bars = 20 μm.Burnicka-Turek et al. BMC Cell Biology 2010, 11:28
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PELO overexpression disrupts actin stress fibers and 
reduces cell growth and spreading
To determine the effect of PELO overexpression, Hep2G
cells were transfected with either Myc-tagged PELO or an
empty pcDNA vector as a control and stable transfected
clones were selected. Expression and specificity of the
transfected construct were confirmed by Western blot
analysis using monoclonal antibody against the c-Myc
epitope. As shown in Figure 2A, the anti-Myc antibody
specifically recognizes a 46 kDa Myc-PELO fusion pro-
tein in extracts of recombinant clones, but not in control
cell line. We then used the clones L3 and L6, which
exhibit higher and lower levels of Myc-PELO expression,
respectively, in further experiments. To determine
cytoskeleton organization in Myc-PELO-overexpressing
cell lines, cells were stained with FITC-phalloidin. In cells
expressing high levels of Myc-PELO (L3), no stress fibers
were detected by phalloidin staining (Figure 2B). How-
ever, F-actin is still present in these cells as shown by dif-
fuse cytoplasmic phalloidin-FITC labelling (Figure 2B). In
contrast, actin stress fibers were intact in low Myc-PELO-
expressing cells (L6) (Figure 2C). These results suggest
that expression of PELO at high levels results in disas-
sembly of stress actin.
Proliferation assays showed a significant reduction in
growth rate of stable Myc-PELO-overexpressing cell lines
L3 and L6 as compared to control cells (Figure 2D). The
level of reduction in growth rate between both Myc-
PELO-overexpressing cell lines correlated with the
expression level of Myc-PELO (Figure 2A). Anchorage-
independent growth is a generally accepted indicator of
the transformed phenotype in vitro. To investigate
whether the overexpression of PELO alters the anchor-
age-independent growth ability of HepG2 hepatoma
cells, we compared the ability of L3 and L6 to growth in
soft agar. As shown in Figure 2E, the number of colonies
in L3 and L6 cell lines was significantly lower than those
of mock-transfected HepG2 cells (LC). The anchorage-
independent growth capacity was also correlated with the
level of PELO protein in each cell line. To investigate
whether the disruption of actin stress fibers in Myc-
PELO-overexpressing cells affects the spreading behav-
iour, cells were seeded onto fibronectin-coated plates. At
30 min after seeding, the majority of Myc-PELO-overex-
pressing and control cells had not spread and exhibited a
round morphology. At 2 h after seeding, 34% and 70% of
L3 and L6 cells were spread, respectively, compared with
90% of control cells (Figure 2F). Taken together, these
results indicate that Myc-PELO-overexpression affects
cell proliferation and spreading following cell adhesion.
PELO interacts with HAX1, EIF3G and SRPX
To determine the molecular basis of PELO association
with the cytoskeleton, a yeast two-hybrid screen was per-
formed to identify PELO-interacting proteins. As a bait,
we cloned full length PELO into the screening vector.
With this screening, several putative interacting partners
for PELO were identified. Among them, two clones con-
tain a cDNA sequence for HAX1, and two clones coding a
sequence of EIF3G and SRPX. The identified cDNA frag-
ments contained the partial coding sequences of HAX1
(amino acid residues 176-279), EIF3G (amino acid resi-
dues 1-320) and SRPX (amino acid residues 265-464).
Several control experiments were performed to assess the
fidelity of these interactions in yeast. Neither the bait nor
HAX1, EIF3G or SRPX vectors autonomously activated
the reporter genes in the yeast two-hybrid system, when
grown in the appropriated nutrient-deficient media
Figure 2 Overexpression of PELO affects actin stress fibers, cell 
growth and spreading in stable PELO-overexpressing cell lines. A, 
Hep2G cells were transfected with Myc-PELO fusion constructs or 
empty vector. Protein extracts from stable control (LC) and Myc-PELO 
expressing cell lines (L1, L3, L6 and L7) were analyzed by immunoblot-
ting with monoclonal anti-Myc tag antibody. The membrane was sub-
sequently reprobed with α-tubulin antibody. B-C, Cells of Myc-PELO-
overexpressing L3 (B) and L6 (C) cell lines were stained with FITC-phal-
loidin. Cell showed diffusely cytoplasmic actin are labelled with arrows 
and that containing stress actin with arrowheads. D, In vitro growth 
properties of control and PELO-overexpressing cells. Growth curves of 
mock-transfected Hep2G (LC), and PELO-transfected clone L3 and L6. 
E, Growth of the same cell lines in soft agar. 0.2 × 104 cells were plated 
per dish. 100% (LC) = 4.4 × 102 colonies. The data points represent the 
means ± SD of three independent experiments. F, Control cells (LC) as 
well as L3 and L6 that expressed PELO at low and high levels, respec-
tively, were seeded onto fibronectin-coated slides for 30 and 120 min. 
Cells were then counted and scored for spreading. White bars repre-
sent L3, black bars L6 and grey bars LC cells. Results are presented as 
percentage of cells that adapted spread morphology at 30 and 120 
min after seeding. 100 cells per well were counted in three separate ex-
periments. Data represent means ± SD.Burnicka-Turek et al. BMC Cell Biology 2010, 11:28
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(minus amino acid histidine, adenine and tryptophan
with addition of 5 mM 3-amino-1, 2, 4 triazole) (data not
shown).
T o identify and verify the region of PELO responsible
for specific interactions with HAX1, EIF3G and SRPX,
several GST-PELO fusion proteins were generated con-
taining deletions of different PELO domains (Figure 3A,
B). Next, the binding activity of the different GST-PELO
fusion proteins with the putative interacting proteins was
tested in a GST pull-down assay. Cells lysates from HeLa
cells transiently transfected with Myc-tagged HAX1,
EIF3G or SRPX expression vectors were incubated with
different GST-PELO fusion proteins bound to glutathi-
one-sepharose beads. After extensive washing, proteins
bound to beads were immunoblotted with monoclonal
anti-Myc antibody. As shown in the top panel of Figure
3C, GST-1 and GST-2 fusion proteins, but not GST-3,
GST-4 and GST-0 interact with the 12 kDa Myc-HAX1
(Figure 3C). Deletion of the acidic tail domain (AT) of
PELO (residues 271-285) in both GST-3 and GST-4
f u s i o n  p r o t e i n s  d e m o n s t r a t e s  t h a t  t h e  A T  d o m a i n  o f
PELO is responsible for binding to HAX1. In further pull-
down assa ys wit h pr ot ein e x tracts of HeLa c e lls trans-
fected with either Myc-tagged EIF3G or SRPX con-
structs, GST-1, GST-2 and GST-3, but not GST-4 and
GST-0 exhibited strong association to the 38 kDa Myc-
EIF3G (Figure 3C, middle panel) and 24 kDa Myc-SRPX,
respectively (Figure 3C, bottom panel). These results
indicate that the c-terminal domain of PELO (residues
268-370) is essential for binding to EIF3G and SRPX in
vitro. Taken together, these results confirm the interac-
tions of PELO with HAX1, EIF3G and SPRX, which were
found as interaction proteins of PELO in a yeast two-
hybrid assay.
The interactions of PELO with the putative interacting
proteins were further studied in HeLa cells, which were
transiently co-transfected with HA-tagged PELO (PELO-
HA) expression vectors and either Myc-tagged HAX1,
EIF3G or SRPX constructs. Cell lysates were subjected to
immunoprecipitation with a monoclonal anti-Myc anti-
b o d y  o r  c o n t r o l  m o u s e  I g G ,  f o l l o w e d  b y  w e s t e r n  b l o t
analysis with a polyclonal anti-HA antibody. A single
polypeptide band of 45 kDa in size, consistent with the
molecular mass of PELO-HA, was detected in input
lysates and in all immunoprecipitated assays with anti-
HA, but not in control mouse IgG-immunoprecipitates
(Figure 4A). In the opposite experiments, lysates of co-
transfected HeLa cells with PELO-HA and either Myc-
tagged HAX1, EIF3G or SRPX construct were immuno-
precipitated with either HA-tag or PELO antibodies. The
precipitates were then immunoblotted and probed with
monoclonal Myc-tag antibodies. Single polypeptide
bands of 12 kDa, 38 kDa and 24 kDa in size, consistent
with the expected molecular masses of cloned Myc-
HAX1, Myc-EIF3G and Myc-SRPX, respectively, were
shown in input lysates and in anti-HA tag and anti-PELO
immunoprecipitates but not in rabbit IgG-immunopre-
cipitates (Figure 4B and 4C). Collectively, these results
clearly demonstrate that PELO forms protein complexes
with HAX1, EIF3G and SRPX in HeLa cells.
Co-localization of PELO and its interacting proteins at the 
cytoskeleton
Similar to the subcellular distribution of PELO, HAX1
was also reported to be localized to actin stress fibers [8].
Transiently co-transfected HeLa cells were immunofluo-
rescent stained with anti-HA and anti-Myc antibodies to
show whether PELO and its binding partners HAX1,
EIF3G or SRPX are associated with the cellular cytoskele-
ton. PELO-HA and Myc-HAX1 were diffusely distributed
in the cytoplasm of co-transfected cells (Figure 5A, panel
i-iii). These results further support our finding that the
overexpression of PELO in stable overexpressing cell lines
disrupts the organization of the actin cytoskeleton.
To overcome the failure to determine the subcellular
localization of the protein interaction in living cells and to
further support the biochemical interactions of PELO
with its putative binding partners, we performed bimo-
lecular fluorescence complementation assays (BiFC).
Figure 3 The acidic tail (AT, residues 371-385), and c-terminal (Pe-
lo-1, residues 268-371) region of PELO is required for binding to 
HAX1, and EIF3G and SPRX, respectively. A, To determine the re-
gions of PELO that are required for its association with HAX1, EIF3G and 
SRPX, four GST-PELO fusion proteins were generated (GST-1, GST-2, 
GST-3 and GST-4) and tested for their ability to bind in GST pull-down 
assays. GST alone (GST-0) was used as control in the assay. B, Recombi-
nant GST-PELO fusion proteins were subjected to SDS-PAGE and 
stained with Coomassie blue. C, Equivalent amounts of GST-PELO and 
GST-0 proteins bound to glutathione-matrices were subsequently in-
cubated with extracts of HeLa cells, which were transfected with either 
Myc-tagged HAX1, EIF3G or SRPX constructs. Western blots containing 
the GST pull-down assays were incubated with monoclonal anti-Myc 
antibodies. Immunoblot analysis revealed that GST-1 and GST-2, but 
not GST-3, GST-4 and GST-0 bound to Myc-HAX1 protein. Except GST-
4 and GST-0, all other GST-PELO fusion proteins exhibit specific associ-
ation to Myc-EIF3G and Myc-SRPX.Burnicka-Turek et al. BMC Cell Biology 2010, 11:28
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This approach is based on the complementation between
two non-fluorescent fragments of EGFP when they are
brought together by interaction of two proteins fused to
each fragment. This assay is effective in determining the
interaction of proteins by visualization of fluorescence on
protein complexes in living cells [9,10]. For BiFC analysis,
we generated an expression vector by fusing the full-
length PELO cDNA in-frame to the C-terminal half of
EGFP (PELO-GFPC), whereas the N-terminal half of
EGFP was fused with HAX1 (HAX1-GFPN), EIF3G
(EIF3G-GFPN) or SRPX (SRPX-GFPN). Cells transfected
Figure 4 PELO interacts with HAX1, EIF3G and SRPX in vivo. A, To-
tal protein from HeLa cells, which are co-transfected with HA-tagged 
PELO and either Myc-tagged HAX1, EIF3G or SRPX constructs, were 
precipitated with monoclonal anti-Myc antibodies. The precipitates of 
co-transfected cells with PELO-HA:Myc-HAX1 (IP1), PELO-HA:Myc-
EIF3G (IP2) and PELO-HA:Myc-SRPX (IP3) were probed in immunoblot 
analysis with polyclonal anti-HA antibodies. IPC, control co-immuno-
precipitation (coIP) assay using anti-mouse IgG serum. B-C, In recipro-
cal coIP experiments, cells lysates from co-transfected HeLa cells were 
precipitated with either polyclonal anti-HA (B) or anti-PELO antibodies 
(C). Precipitated proteins (IP) were detected with anti-Myc antibodies. 
IPC, control coIP experiments using anti-rabbit IgG serum.
Figure 5 Cellular localization of PELO-interacting proteins. A, 
HeLa cells were transiently co-transfected with PELO-HA and Myc-
HAX1 and immunostained with anti-HA (panel i) and anti-Myc (panel 
ii) antibodies. A co-localization of both proteins is mainly diffused in cy-
toplasm (panel iii). B-N, Bimolecular fluorescence complementation 
analysis (BiFC) revealed that protein complexes between PELO and 
HAX1, EIF3G or SRPX are localized at the cytoskeleton. B-E, Cells trans-
fected with GFPN (B) and GFPC (C), PELO-GFPC (D) and HAX1-GFPN (E) 
alone did not show any fluorescence. F-N, HeLa cells were transiently 
co-transfected with PELO-GFPC and either HAX1-GFPN (F), EIF3G-
GFPN (G), SRPX-GFPN (M) or MOS-GFPN (N) as control. Complementa-
tion of both non-fluorescent GFP halves resulted in functional fluoro-
phores, which is diagnostic for stable interaction of the fusion proteins. 
The reconstituted GFP-fluorescence (BiFC) is shown in green and 
mainly localized at the cytoskeleton. Absence of GFP-fluorescence (N) 
indicates lack of BiFC. DNA staining is shown in blue. Scale bars = 20 
μm.Burnicka-Turek et al. BMC Cell Biology 2010, 11:28
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with either both empty vectors or with either PELO-
GFPC or HAX1-GFPN alone did not show any fluores-
cence (Figure 5B-E). In contrast, cells co-transfected with
PELO-GFPC and HAX1-GFPN displayed fluorescence,
which was mainly accumulated at the cytoskeletal fila-
ments (Figure 5F). Similar patterns of subcellular local-
ization of fluorescent complementation were observed
when the fusion proteins PELO-GFPC with either EIF3G-
GFPN or SRPX-GFPN were expressed in HeLa cells (Fig-
ure 5G and 5M). In a control experiment, cells co-trans-
fected with PELO-GFPC and MOS-GFPN containing the
sequence of the MOS gene, which did not show to be an
interacting-protein of PELO, did not reveal any fluores-
cent staining (Figure 5N). Taken together, these results
demonstrate that PELO interacts with HAX1, EIF3G and
SRPX, and the resulting protein complexes are associated
with the cytoskeleton.
Discussion
Current data on the consequences of PELO deficiency in
Drosophila and mouse suggest that PELO is involved in
the regulation of stem cell renewal [6,7]. In yeast Dom 34/
PELO has been described to play a critical role in a new
surveillance pathway termed No-Go decay [11,12]. This
p a t h w a y  c l e a r s  c e l l s  f r o m  m R N As  t h a t  i n d u c e  t r a n s l a -
tional stalls through endonuclease cleavage that is
thought to be mediated by Dom34/PELO and its interact-
ing protein Hbs1. Dom34 and Hbs1 are related to the
translation termination factor eRF1 and eRF3, respec-
tively. Beside the role of eRF1 and eRF3 in translation,
both proteins are involved in cytoskeleton organization in
yeast [13]. Deletion of eRF3 disrupted actin cytoskeleton
in most cells. In contrast, these effects were not observed
in cell deficient for eRF1, a structural homolog PELO
[13].
Following cell adhesion, cells rearrange their cytoskele-
ton and spread by increasing their contact with extracel-
lular matrix, and through formation of actin stress fibers
and focal adhesions [14-16]. Analyses of stable PELO-
expressing cell lines revealed that cell lines showing
higher PELO expression, which was correlated with
reduced growth rates, spread much slower. These results
suggest that expression of PELO at higher levels resulted
in the disassembly of actin stress fibers and reduced cell
spreading.
T o  g a i n  m o r e  i n s i g h t  i n t o  t h e  f u n c t i o n  o f  P E L O ,  a
cDNA library was screened by yeast two-hybrid assay for
PELO-interacting proteins. This lead to the identification
of three proteins that interact with PELO: multifunc-
tional protein HAX1, the eukaryotic initiation factor
EIF3G and the apoptosis-inducing tumor suppressor
SRPX/RDS. The interactions of PELO with HAX1, EIF3G
and SRPX in yeast were corroborated by three lines of
evidences. All GST-PELO fusion proteins except those
lacking the C-terminal domain of PELO extracted the
recombinant Myc-HAX1, Myc-EIF3G and Myc-SRPX
from extracts of transiently transfected HeLa cells sug-
gesting that the C-terminal domain of PELO is responsi-
ble for specific binding with interacting proteins. PELO
was specifically co-immunoprecipitated with HAX1,
EIF3G and SRPX from cell extracts. Finally, BiFC analysis
revealed that formed protein complexes are localized at
the cytoskeleton of mammalian cells.
HAX1, a 34 kDa polypeptide, interacts with a heteroge-
neous group of proteins including the α-subunit of the
heterodimeric G-protein Gα13 and cortactin, which are
colocalized with HAX1 at the actin cytoskeleton. Overex-
pression of HAX1 in stably transfected cells reduces the
formation of actin stress fibers [8], a phenotype which
was also shown in PELO-overexpressing cell line. HAX1
is a multifunctional protein, active in different cellular
compartments and involved in various cellular processes.
Attention has been focused on its function in apoptosis
and regulation of the actin cytoskeleton. However, it has
been reported that HAX1 is an RNA-binding protein and
may be has a regulatory role in stabilization and/or trans-
port of mRNA [17,18].
EIF3G represents a subunit of the eukaryotic transla-
tion initiation factor 3 (eIF3). The eIF3 complex consists
of at least 13 subunits and plays a central role in the path-
way of protein translation initiation [19-21]. EIF3G has
been reported to associate with the cytoskeletal protein
4.1R and with AIF that induce apoptosis through inhibi-
tion of protein synthesis [22,23].
A third PELO-interacting protein, SRPX, was originally
isolated as a suppressor of v-src transformation [24,25].
Subsequent reports found that SRPX induces apoptosis
via a novel ER-mediated pathway and suggest that this
pathway might contribute to the suppression of tumor
formation [26].
Various studies have shown that mRNA, polysomes
and different components of the protein synthesis
machinery, such as aminoacyl-tRNA, eukaryotic initia-
tion factors and elongation factors are associated with the
cytoskeleton and that this association may influence the
transport and translation of mRNA [27,28]. Therefore,
binding of PELO to cytoskeleton-associated proteins may
facilitate PELO to detect and degrade aberrant mRNAs,
at which the ribosome is stalled during translation.
PELO has an endonuclease activity that catalyzes the
mRNA cleavage near the stall site of the ribosome and
subsequent degradation [29]. However, mutations inacti-
vating the proposed endonuclease domain do not affect
No-Go decay (NGD). These results suggest that the pro-
p o s e d  e n d o n u c l e a s e  a c t i v i t y  o f  D o m 3 4 / P E L O  i s  n o t
required for mRNA cleavage in NGD [30]. The interac-
tions of PELO with components of the protein synthesis
machinery and apoptosis raise the question whetherBurnicka-Turek et al. BMC Cell Biology 2010, 11:28
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PELO has a role in linking mRNA and protein synthesis
to apoptosis. Several studies revealed an increase of
mRNA degradation during cell death. Such increase of
mRNA degradation seems to be correlated very well with
the inhibition of protein synthesis [31,32]. Therefore, it is
probable that mRNA decay makes a significant contribu-
tion to the reduction in global protein synthesis during
apoptosis [33]. The link between mRNA decay and pro-
tein synthesis has been supported by the observation
showing that the RNaseL regulates mitochondrial mRNA
decay during apoptosis through its interaction with mito-
chondria initiation factor 2 (IF2 mt). This interaction
brings RNaseL into close association with the mRNA,
where it can act as an endonuclease [34]. These observa-
tions lead us to suggest that the interaction of PELO with
EIF3G mediates the inhibition of protein synthesis during
cell death by global mRNA decay or by inhibiting transla-
tion initiation.
Conclusion
In summary, the experiments here have demonstrated
that PELO is localized to actin cytoskeleton. Yeast two-
hybrid, GST pull-down and coimmunoprecipitation stud-
ies revealed that PELO interacts with HAX1, EIF3G and
SRPX. These results were further confirmed by BiFC
assay showing that protein complexes resulting from the
interactions between PELO and either HAX1, EIF3G or
SRPX were mainly localized to cytoskeletal filaments.
Methods
Production of anti-PELO antibodies
Antibodies against the full-length of human PELO fused
to GST (GST-PELO) were raised in rabbits (see below).
Rabbits were initially injected with 1.0 mg of purified
GST-PELO antigen mixed 1:1 with complete Freund's
adjuvant followed by two boosts, at 3-weeks intervals,
with 0.5 mg of antigen mixed 1:1 with incomplete Fre-
und's adjuvant. The antibodies were affinity purified by
absorption to the same fusion protein covalently coupled
to HiTrap NHS-activated columns (Amersham Biosci-
ences, Braunschweig, Germany) following the manufac-
turer's procedures.
Cell fractionation
HeLa cells were washed twice with PBS, and scraped in
0.5 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 2 mM
EDTA, 2 mM EGTA, 1 mM sodium vanadate, 1 mM
dithiothreitol, 0.1% Triton X-100, protease inhibitor
cocktail) on ice for 15 min. The cells were homogenized
with a glass Dounce homogenizer. The nuclear fraction
was collected by centrifugation at 600 × g for 20 min at
4°C. The supernatant was further centrifuged at 100 000
× g for 60 min to collect a cytoplasmic soluble superna-
tant and a plasma membrane pellet. The nuclear and
plasma membrane pellet was extracted with RIPA lysis
buffer (Santa Cruz Biotechnologie, Heidelberg, Ger-
many). To obtain a cytoskeletal fraction, cells were
scraped on ice in cytoskeleton-stabilizing buffer (50 mM
NaCl, 10 mM Pipes, pH 6.8, 3 mM MgCl2, 0.5% Triton X-
100, protease inhibitor cocktail), and centrifuged at 14000
× g at 4°C. The pellet was resuspended in cytoskeleton-
stabilizing buffer containing 0.5% SDS.
Yeast two-hybrid screening
To identify putative PELO-interacting proteins, human
prostate cDNA library in pACT2 (BD Bioscience, Heidel-
berg, Germany) was screened using the pGBK7-PELO
bait vector according to the manufacturer's instructions.
Using sequential transformations, the bait vector and
then the prey library were transformed into the AH109
strain. After the first transfection, the bait vector was
characterized for lack of autoactivation by growing the
PELO-transformants on plate lacking histidine and ade-
nine. Double transformants were initially selected by
growth on plates lacking histidine and adenine in the
presence of 5 mM 3-amino-1,2,3-triazole (Sigma-Aldrich,
Munich, Germany). From 1 × 107  transformants, 98
clones appeared after 5 days. These colonies were plated
on plates lacking both histidine and adenine and contain-
ing β-galactosidase. Approximately 56 of those displayed
clear activation of all three reporter genes, and 42 of these
were selected for isolation of the prey plasmids and
sequencing of the cDNA encoding the PELO-interacting
protein.
Expression of proteins in mammalian cells
For transient expression, human HeLa cells were grown
for 24 h on 6-well plates (1.5 × 105 cells/well) prior to
transfection with recombinant construct (2 μg/well)
using Lipofectamin 2000 transfection reagent (Invitro-
gen, Karlsruhe, Germany) according to the manufac-
turer's procedures. Transfected cells were further
cultured for 2 days prior to harvesting for co-immuno-
precipitation studies. For stable expression, HepG2 cells
were transfected either with pcDNA™ 3.1/Myc-His A(+)
vector alone (Invitrogen) or with recombinant vector
containing the full-length PELO  cDNA, which was in-
frame with the Myc tag. The cells were trypsinized 48 h
after transfection, and cultured in medium containing
600 μg/ml of G418. After 2 weeks, single colonies were
picked, cultured and the expression of Myc-tagged PELO
was analysed by immunoblotting using Myc tag-specific
monoclonal antibody (1:200 dilution, Santa Cruz Bio-
technologie).
Immunoprecipitation and Immunoblotting
The plasmid constructs Myc-HAX1, Myc-EIF3G and
Myc-SRPX, which were used in co-immunoprecipitationBurnicka-Turek et al. BMC Cell Biology 2010, 11:28
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experiments, were generated by amplification the cDNA
fragments of HAX1, EIF3G und SRPX using the identi-
fied prey vectors as template and the sense primer Y2HF:
5'-TTC GAT GAT GAA GAT ACC CCA AAC-3' and
antisense primer Y2HR: 5'-GTG AAC TTG CGG GGT
TTT TCA GTA TCT AC-3'. The amplified PCR frag-
ments were inserted into the EcoRI/XhoI sites of the
pCMV-Myc vector (BD Bioscience). The PELO-HA con-
struct was generated by insertion of cDNA fragment of
full-length human PELO into the EcoRI/XhoI sites of the
pCMV-HA vector (BD Bioscience), which had a HA
epitope linked to the N-terminus of PELO protein. HeLa
cells were transiently co-transfected with PELO-HA and
either of the Myc-HAX1, Myc-EIF3G or Myc-SRPX con-
structs. For co-immunopreciptation, 500 μl of whole cell
lysates were firstly pre-cleared by incubation with 50 μl
protein A/G-agarose beads (Roche, Mannheim, Ger-
many) for 3 h. The pre-cleared lysates were then incu-
bated with either 10 μl mouse monoclonal anti-Myc
(Santa Cruz Biotechnology), 10 μl rabbit polyclonal anti-
HA (BD Biosciences) or 4 μl polyclonal anti-PELO anti-
bodies for 2 h at 4°C. In control assays, lysates were sub-
jected to immunoprecipition using 4 μl of mouse IgG.
The immunoprecipitates were recovered by incubating
the mixture overnight at 4°C with 50 μl protein A/G-aga-
rose beads. After extensive washing of the beads, bound
proteins were separated by SDS-PAGE and transferred to
nitrocellulose membrane Hybond-C (Amersham Biosci-
ences). Membranes were blocked for 1 h in 5% non-fat
dry milk in PBS containing 0.2% Tween20 and then incu-
bated overnight at 4°C with either anti-Myc, anti-HA or
anti-PELO antibodies (1:500 dilution). Bound antibodies
were then visualized by secondary incubation with goat
anti-rabbit IgG horseradish peroxidase conjugate or goat
anti-mouse IgG horseradish peroxidase conjugate
(Sigma-Aldrich) followed by SuperSignal®  West Pico
Chemiluminescent Substrate (Pierce, USA).
GST pull-down assay
For generation of glutathione S-transferase-PELO and
truncated fusion constructs, cDNA fragments encoding
full-length human Pelo (GST-1, 2-385 aa), and truncated
Pelo - GST-2 (136-385 aa), GST-3 (2-371 aa) and GST-4
(2-268 aa) were amplified by PCR using human Pelo
cDNA as template and appropriate primers containing
restriction site tags. Oligonucleotide sequences are given
in Additional file 1. The amplified fragments were cloned
in-frame into EcoRI/XhoI sites of the pET41a(+) vector
(Novagen, Darmstadt, Germany). B121(DE3)pLysS bac-
teria were transformed with either empty GST vector
(GST-0) or GST-PELO fusion vectors and grown at 37°C
to log phase (A600 of 0.6). Expression of fusion protein
was induced by growing the cells at 30°C for 4 h in the
presence of 100 μM 1-thio-β-D-galactopyranoside. GST-
PELO fusion proteins were purified using the GST-bind™
Purification Kit (Novagen, Darmstadt, Germany). HeLa
cell protein extracts (500 mg protein) were incubated
with 50 μl (100 μg) of individual fusion protein or GST
alone in the GST binding buffer for 3 h at 4°C. After cen-
trifugation, pellets were washed 3 times with lysis buffer
B, boiled in sample buffer , followed by SDS-P AGE and
Western blot analysis.
100 μl of GST-bind-resin were transferred to a clean 1.5
ml microcentrifuge tube and washed 3 times with 250 μl
of 1× GST Bind/Wash buffer. The beads were resus-
pended in 50 μl 1× GST Bind/Wash buffer and incubated
with 50 μl (100 μg) of individual GST fusion protein or
GST alone for 1 h at RT on a rocking platform. Beads
were washed 3 times with 250 μl of 1× GST Bind/Wash
buffer and 100 μl of HeLa cell lysates (300 - 500 μg pro-
tein) were added to the reaction tube and the mixture was
incubated for 2 h at 4°C on a rocking platform. The beads
were then washed 3 times with 250 μl of lysis buffer B.
Finally, proteins binding to the beads were resuspended
with NuPAGE SDS sample buffer, separated by SDS-
PAGE and analyzed by Western blotting using anti-c-Myc
primary antibodies (dilution 1:200) and goat anti-mouse
IgG conjugated with horseradish peroxidase secondary
antibodies. Immunoreactive polypeptides were then visu-
alized by the SuperSignal® West Pico Chemiluminescent
Substrate as previously described.
Spreading, proliferation and soft agar assays
HepG2 cells stably transfected with empty pcDNA3A-
Myc or pcDNA-PELO plasmids were seeded at a density
of 2 × 104 cell/well onto 96-well plates that were pre-
coated with 10 μg/ml fibronectin (Sigma-Aldrich). Cells
were allowed to spread for 60 min at 37°C in growth
medium. Non-adherent cells were removed by two
washes with pre-warmed PBS. The percentage of
spreaded cells was evaluated 30 min and 120 min after
seeding by counting the number of non-spread cells
under the microscope (Olympus BX60, Hamburg, Ger-
many). The non-spread cells were defined as round cells,
whereas spread cells were defined as those that lacked a
rounded shape and had extended membrane protrusions
[35]. To obtain an index of cell spreading, adherent cells
were photographed with a digital camera. According to
their distinct differences in surface area and morphology,
the cells were divided into two groups: small round cells
showing no obvious sign of spreading (group 1), and flat
cells in the process of spreading or already well spread
(group 2). Monitoring the proportion of cells in group 1
to total cells at a given time point after seeding serves as a
measure of spreading velocity. At least 100 cells per well
were counted in three independent experiments.
For cell proliferation assay, stably transfected HepG2
cells with empty pcDNA3A-Myc or pcDNA-PELO plas-Burnicka-Turek et al. BMC Cell Biology 2010, 11:28
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mids were seeded in triplicate in 24-well plates (0.25 ×
105 cells per well) and cultivated for 5 days. Every day,
cells were washed, trypsinized and proliferation of cells
was evaluated by counting the number of cells under the
microscope using a Neubauer counting chamber.
For soft agar colony formation assay, single cells of sta-
bly transfected HepG2 cell were resuspended in semi-
solid medium containing 0.35% Bacto-agarose supple-
mented with 20% FBS, 750 μg/ml G418 and 0.8% agarose.
This cell suspension containing 0.2 × 104 cells/well was
immediately plated into 6-well plates coated with 0.3%
agar in cell culture medium (2 ml per well) and cultured
at 37°C with 5% CO2. After 3 weeks, the top layer of the
culture was stained with 0.1% crystal violet for 1 h. The
culture was analyzed in triplicate and colonies larger than
100 μm in diameter were counted.
Immunofluorescence
Cells were grown on chamber slide overnight, fixed with
4% paraformaldehyde in PBS for 15 min. Subsequently,
cells were washed with PBS, preincubated with 0.2% Tri-
ton X-100 in PBS for 30 min and blocked with 10% goat
serum in PBS for 1 h. Cells were incubated overnight at
4°C with 100 μl of primary antibody diluted in 1% goat
serum in PBS. Primary antibodies were as followed: a
1:200 dilution of anti-PELO antibody, a 1:200 of anti-Myc
and anti-HA antibodies. Cells were washed with PBS and
then incubated with a 1:500 dilution of the appropriate
FITC-coupled secondary antibody (Sigma-Aldrich) in 1%
goat serum in PBS for 2 h. Cells were washed and then
incubated with 1:100 dilution of FITC-phalloidin (Sigma-
Aldrich) in PBS for 20 min. Cells were mounted with
Vectashield mounting reagent (Vector, Burlingame, USA)
prior to fluorescence microscopy (Olympus, Hamburg,
Germany).
Bimolecular fluorescence complementation (BiFC) assay
The pEGFP-N1 (BD Bioscience) and pQM-Ntag/B
(Abcam, UK) vectors were used as start plasmids to con-
struct the BiFC vector FPCA-V1 and FPCA-V2, respec-
tively. To generate the FPCA-V2 and FPCA-V1,
fragments containing the coding sequence for the resi-
dues 1-157 or the residues 158-239 of the EGFP fragment
were amplified by PCR and inserted into the backbone of
the pQM-Ntag/B and pEGFP-N1 vectors, respectively.
The full-length cDNA fragment of human Pelo (1-385 aa)
was amplified and cloned into the XhoI/BamHI-digested
FPCA-V1 to generate PELO-GFPC construct. The cloned
cDNAs of HAX1 (178-279 aa), EIF3G (1-320 aa) and
SRPX (265-464 aa) were amplified by PCR and inserted
into HindIII/BglII-digested FPCA-V2 to generate HAX1-
GFPN, EIF3G-GFPN and SRPX-GFPN constructs,
respectively. Primer sequences used for generation a
cDNA fragments are presented in Additional file 1. HeLa
cells grown on chamber slides were transiently co-trans-
fected with PELO-GFPC and either HAX1-GFPN,
EIF3G-GFPN or SRPX-GFPN constructs. Transfected
cells were grown at 37°C for 24 h, incubated for 2 h at
30°C and then fixed in 4% paraformaldehyde in PBS for
10 min. Single transfection of the plasmids used for BiFC
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